Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Document Type
- Journal article (12)
Language
- English (12)
Keywords
- Medizin (2)
- juvenile idiopathic arthritis (2)
- ACP5 (1)
- AD-AID (1)
- AICDA (1)
- AID-ΔE4a (1)
- Age (1)
- Antibody (1)
- B cells (1)
- CRMO (1)
- CVID (1)
- England (1)
- European Society for Immunodeficiencies (ESID) (1)
- German PID-NET registry (1)
- HRQOL (1)
- Hemagglutination inhibition (1)
- IL-12B (1)
- IL-12p40 (1)
- IL12B (1)
- IgG substitution therapy (1)
- Immunogenicity (1)
- PID prevalence (1)
- Prevalence (1)
- Risk (1)
- Safety (1)
- Vaccine (1)
- Varizellen-Virus (1)
- Viruses (1)
- alkaline phosphatase (1)
- antinuclear antibodies (1)
- asfotase alfa (1)
- autoimmunity (1)
- cells (1)
- cerebral calcification (1)
- children (1)
- chronic non-bacterial osteomyelitis (1)
- cidofovir (1)
- cytokine (1)
- deficiency (1)
- double negative B cells (1)
- dysplasia (1)
- expression (1)
- gene (1)
- hyper-IgM syndrome type 2 (HIGM2) (1)
- hypophosphatasia (1)
- immunodeficiency (1)
- medicine (1)
- mutational targeting (1)
- osteomalacia (1)
- pediatrics (1)
- physical activity (1)
- polymorphism (1)
- primary immunodeficiency (PID) (1)
- promoter (1)
- rare bone disease (1)
- registry for primary immunodeficiency (1)
- resistant acid phosphatase (1)
- rickets (1)
- serum (1)
- somatic hypermutation (1)
- spondyloenchondrodysplasia (1)
- synovial fluid (1)
- systemic lupus erythematosus (1)
- trap (1)
- type I interferonopathy (1)
- varicella-zoster virus immunosuppression (1)
Juvenile idiopathic arthritis (JIA) encompasses a heterogeneous group of diseases. The appearance of antinuclear antibodies (ANAs) in almost half of the patients suggests B cell dysregulation as a distinct pathomechanism in these patients. Additionally, ANAs were considered potential biomarkers encompassing a clinically homogenous subgroup of JIA patients. However, in ANA+ JIA patients, the site of dysregulated B cell activation as well as the B cell subsets involved in this process is still unknown. Hence, in this cross-sectional study, we aimed in an explorative approach at characterizing potential divergences in B cell differentiation in ANA+ JIA patients by assessing the distribution of peripheral blood (PB) and synovial fluid (SF) B cell subpopulations using flow cytometry. The frequency of transitional as well as switched-memory B cells was higher in PB of JIA patients than in healthy controls. There were no differences in the distribution of B cell subsets between ANA- and ANA+ patients in PB. However, the composition of SF B cells was different between ANA- and ANA+ patients with increased frequencies of CD21\(^{lo/−}\)CD27\(^−\)IgM\(^−\) “double negative” (DN) B cells in the latter. DN B cells might be a characteristic subset expanding in the joints of ANA+ JIA patients and are potentially involved in the antinuclear immune response in these patients. The results of our explorative study might foster further research dissecting the pathogenesis of ANA+ JIA patients.